GRDN Depreciation And Amortization

Annual D&A

$18.23 M
+$1.67 M+10.09%

December 1, 2023

Summary

Performance

1-Year Change

+10.09%

3-Year Change

+5.66%

5-Year Change

+38.83%

15-Year Change

+38.83%

GRDN Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.11%
GRDN annual depreciation & amortization is higher than 78.11% of companies in Healthcare sector

High & Low

All-time High

$18.23 M
GRDN annual depreciation & amortization is currently at an all-time high

3-Year Low

$16.53 M
GRDN annual depreciation & amortization is currently +10.31% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
GRDN previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
GRDN next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$1.01 B
GRDN annual total expenses is $1.01 billion

Annual Operating Expenses

$167.36 M
GRDN annual total operating expenses is $167.36 million

Annual Cost Of Goods Sold

$837.88 M
GRDN annual cost of goods sold is $837.88 million

Annual Interest Expense

$2.86 M
GRDN annual interest expense is $2.86 million

Quarterly D&A

N/A

September 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

GRDN Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$11.58 M
GRDN quarterly depreciation & amortization is currently at an all-time high

3-Year Low

$4.02 M
GRDN quarterly depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GRDN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
GRDN next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$419.01 M
GRDN quarterly total expenses is $419.01 million

Quarterly Operating Expenses

$165.49 M
GRDN quarterly total operating expenses is $165.49 million

Quarterly Cost Of Goods Sold

$253.51 M
GRDN quarterly cost of goods sold is $253.51 million

Quarterly Interest Expense

$1.03 M
GRDN quarterly interest expense is $1.03 million

TTM D&A

N/A

September 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

GRDN TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$18.23 M
GRDN TTM depreciation & amortization is currently at an all-time high

3-Year Low

$4.07 M
GRDN TTM depreciation & amortization is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
GRDN previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

N/A
GRDN next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$1.01 B
GRDN annual total expenses is $1.01 billion

Annual Operating Expenses

$167.36 M
GRDN annual total operating expenses is $167.36 million

TTM Cost Of Goods Sold

$718.75 M
GRDN TTM cost of goods sold is $718.75 million

TTM Interest Expense

$2.83 M
GRDN TTM interest expense is $2.83 million

GRDN Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.1%--
3 y3 years+5.7%--
5 y5 years+38.8%--

GRDN Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+10.3%
5 y5-yearat high+15.0%
alltimeall timeat high+38.8%

Guardian Pharmacy Services Depreciation And Amortization History

DateAnnualQuarterlyTTM
Dec 2023
$18.23 M(+10.1%)
$4.71 M(+1.6%)
$18.23 M(+34.9%)
Sep 2023
-
$4.64 M(+4.8%)
$13.52 M(+52.2%)
Jun 2023
-
$4.42 M(-0.8%)
$8.88 M(+4.8%)
Mar 2023
-
$4.46 M(+10.9%)
$8.48 M(+4.8%)
Dec 2022
$16.56 M(+0.2%)
-
-
Jun 2022
-
$4.02 M(-1.2%)
$8.09 M(+98.8%)
Mar 2022
-
$4.07 M
$4.07 M
DateAnnualQuarterlyTTM
Dec 2021
$16.53 M(-4.2%)
-
-
Mar 2021
-
$4.27 M(+1.8%)
$4.27 M(-72.9%)
Dec 2020
$17.26 M(+8.9%)
-
-
Mar 2020
-
$4.19 M(-63.8%)
$15.77 M(+36.2%)
Dec 2019
$15.85 M(+20.7%)
-
-
Sep 2019
-
$11.58 M
$11.58 M
Dec 2018
$13.13 M
-
-

FAQ

  • What is Guardian Pharmacy Services annual depreciation & amortization?
  • What is the all time high annual D&A for Guardian Pharmacy Services?
  • What is Guardian Pharmacy Services annual D&A year-on-year change?
  • What is the all time high quarterly D&A for Guardian Pharmacy Services?
  • What is the all time high TTM D&A for Guardian Pharmacy Services?

What is Guardian Pharmacy Services annual depreciation & amortization?

The current annual D&A of GRDN is $18.23 M

What is the all time high annual D&A for Guardian Pharmacy Services?

Guardian Pharmacy Services all-time high annual depreciation & amortization is $18.23 M

What is Guardian Pharmacy Services annual D&A year-on-year change?

Over the past year, GRDN annual depreciation & amortization has changed by +$1.67 M (+10.09%)

What is the all time high quarterly D&A for Guardian Pharmacy Services?

Guardian Pharmacy Services all-time high quarterly depreciation & amortization is $11.58 M

What is the all time high TTM D&A for Guardian Pharmacy Services?

Guardian Pharmacy Services all-time high TTM depreciation & amortization is $18.23 M